UNSPSC 51334401: Mindoperone

This classification denotes an anxiolytic with the molecular formula C25H29FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 556OP2G5M2, chemically known as butyrophenone, 4-fluoro-4-(4-(6-methoxy-2-methylindol-3-yl)piperidino)- but generally known as mindoperone, which bears US NIH Compound Identifier 172296. European Medicines Agency schedules Mindoperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08977MIG.

UNSPSC 51334401 Mindoperone is a Commodity code that frames pharmaceutical and medical countermeasure procurement, though the recent state and local activity under this code reflects procurement of naloxone and drug deactivation systems rather than the code's nominal product name. State and local governments use this code to acquire emergency response pharmaceuticals and harm-reduction equipment that support public health and community safety initiatives. The issuing bodies soliciting under this code include county health departments and public health agencies.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 to procure 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement, with a response deadline of July 26, 2023, required vendors to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, and comply with drug-free workplace certification and E-Verify requirements. The contract was structured as a two-year initial term with a one-year renewal option, subject to a three-month probationary period, and potentially funded through FEMA, which introduced additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.